[go: up one dir, main page]

MX2015010561A - Sintesis asimetrica de una pirrolidin-2-carboxamida sustituida. - Google Patents

Sintesis asimetrica de una pirrolidin-2-carboxamida sustituida.

Info

Publication number
MX2015010561A
MX2015010561A MX2015010561A MX2015010561A MX2015010561A MX 2015010561 A MX2015010561 A MX 2015010561A MX 2015010561 A MX2015010561 A MX 2015010561A MX 2015010561 A MX2015010561 A MX 2015010561A MX 2015010561 A MX2015010561 A MX 2015010561A
Authority
MX
Mexico
Prior art keywords
carboxamide
asymmetric synthesis
substituted pyrrolidine
chloro
phenyl
Prior art date
Application number
MX2015010561A
Other languages
English (en)
Other versions
MX365948B (es
Inventor
Daniel Fishlock
Lianhe Shu
Chen Gu
Pankaj Devdatta Rege
Keshab Sarma
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2015010561A publication Critical patent/MX2015010561A/es
Publication of MX365948B publication Critical patent/MX365948B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epidemiology (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)

Abstract

La presente invención proporciona un método mejorado para la producción a gran escala del compuesto ácido 4- {[(2R,3S,4R,5S)-3 -(3-cloro-2-fluoro-fenil)-4-(4-cloro-2-fluoro-fenil)-4-ciano-5-(2 ,2-dimetil-propil)-pirrolidín-2-carbonil]-amino}-3-metoxi-benzoic o.
MX2015010561A 2013-02-21 2014-02-18 Sintesis asimetrica de una pirrolidin-2-carboxamida sustituida. MX365948B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361767395P 2013-02-21 2013-02-21
US201361909520P 2013-11-27 2013-11-27
PCT/EP2014/053057 WO2014128094A1 (en) 2013-02-21 2014-02-18 Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide

Publications (2)

Publication Number Publication Date
MX2015010561A true MX2015010561A (es) 2015-11-16
MX365948B MX365948B (es) 2019-06-19

Family

ID=50179579

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010561A MX365948B (es) 2013-02-21 2014-02-18 Sintesis asimetrica de una pirrolidin-2-carboxamida sustituida.

Country Status (18)

Country Link
US (1) US9828340B2 (es)
EP (1) EP2958893B1 (es)
JP (1) JP6148351B2 (es)
KR (1) KR101726116B1 (es)
CN (2) CN107686459A (es)
AU (1) AU2014220865B2 (es)
BR (1) BR112015015880B1 (es)
CA (1) CA2894826C (es)
DK (1) DK2958893T3 (es)
ES (1) ES2630392T3 (es)
HU (1) HUE033534T2 (es)
IL (1) IL239888B (es)
MX (1) MX365948B (es)
PL (1) PL2958893T3 (es)
RU (1) RU2015133939A (es)
SG (1) SG11201505150TA (es)
SI (1) SI2958893T1 (es)
WO (1) WO2014128094A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2943571A1 (en) 2014-04-15 2015-10-22 F. Hoffmann-La Roche Ag Solid forms of a pharmaceutically active compound
GB201919219D0 (en) 2019-12-23 2020-02-05 Otsuka Pharma Co Ltd Cancer biomarkers
AU2021333983A1 (en) 2020-08-27 2023-01-05 Otsuka Pharmaceutical Co., Ltd. Biomarkers for cancer therapy using MDM2 antagonists
GB202103080D0 (en) 2021-03-04 2021-04-21 Otsuka Pharma Co Ltd Cancer biomarkers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8354444B2 (en) * 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
US20120010235A1 (en) * 2010-07-12 2012-01-12 Xin-Jie Chu N-substituted pyrrolidines
US20120046306A1 (en) 2010-08-18 2012-02-23 David Joseph Bartkovitz Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists
US20120065210A1 (en) * 2010-09-15 2012-03-15 Xin-Jie Chu Substituted hexahydropyrrolo[1,2-c]imidazolones

Also Published As

Publication number Publication date
SI2958893T1 (sl) 2017-08-31
US9828340B2 (en) 2017-11-28
PL2958893T3 (pl) 2017-09-29
IL239888A0 (en) 2015-08-31
BR112015015880B1 (pt) 2022-07-19
JP6148351B2 (ja) 2017-06-14
US20160002158A1 (en) 2016-01-07
AU2014220865A8 (en) 2015-08-20
CA2894826A1 (en) 2014-08-28
HK1211294A1 (en) 2016-05-20
AU2014220865B2 (en) 2017-03-30
MX365948B (es) 2019-06-19
ES2630392T3 (es) 2017-08-21
CN105026370B (zh) 2017-11-10
HUE033534T2 (en) 2017-12-28
KR101726116B1 (ko) 2017-04-11
CA2894826C (en) 2021-03-23
SG11201505150TA (en) 2015-09-29
JP2016509037A (ja) 2016-03-24
EP2958893A1 (en) 2015-12-30
IL239888B (en) 2018-11-29
BR112015015880A2 (pt) 2017-07-11
WO2014128094A1 (en) 2014-08-28
RU2015133939A (ru) 2017-03-27
CN107686459A (zh) 2018-02-13
AU2014220865A1 (en) 2015-07-02
KR20150109439A (ko) 2015-10-01
EP2958893B1 (en) 2017-05-03
CN105026370A (zh) 2015-11-04
DK2958893T3 (en) 2017-07-10

Similar Documents

Publication Publication Date Title
PH12019502286A1 (en) Process for preparing an optically active pyrimidinium compounds
NZ702752A (en) Methods for synthesizing amatoxin building block and amatoxins
PH12019502386A1 (en) Process for preparing s-containing pyrimidinium compounds
NZ630196A (en) Cyclic amides as metap-2 inhibitors
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
WO2015008218A3 (en) Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant
CY1116974T1 (el) Παραγωγα 5-υδροξυπυριμιδινο-4-καρβοξαμιδιου
MX2014014838A (es) Nuevos derivados de depsipeptidos ciclicos y agentes para el control de organismos dañinos que comprenden los mismos.
MY176465A (en) Synthetic route to 2?-deoxy-2?,2?-difluorotetrahydrouridines
IN2013CH05455A (es)
MX2017008280A (es) Proceso para elaborar cenicriviroc y analogos relacionados.
MY160902A (en) Process for the preparation of the L-arginine salt of perindopril
MX365948B (es) Sintesis asimetrica de una pirrolidin-2-carboxamida sustituida.
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
NZ720106A (en) A process for the preparation of regadenoson
MX2016007186A (es) Nuevo procedimiento de sintesis de la agomelatina.
WO2014141294A3 (en) An improved process for the synthesis of melphalan and the hydrochloride salt
MX376203B (es) Un proceso novedoso para la sintesis de 1-aril-1-trifluoro-metil-ciclopropanos.
AR100095A1 (es) Formas sólidas del ácido {[(2r,3s,4r,5s)-4-(4-cloro-2-fluoro-fenil)-3-(3-cloro-2-fluoro-fenil)-4-ciano-5-(2,2-dimetil-propil)-pirrolidin-2-carbonil]-amino}-3-metoxi-benzoico
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds
CL2008003065A1 (es) Proceso para preparar un compuesto derivado de acido carbamoil-fosfonico o del acido carbamoil-fosfinico.
WO2016202808A3 (en) NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES
WO2014060575A3 (en) Process for the enantioselective synthesis of a tetrahydrobenzazepine compound
MX2013011151A (es) Proceso para la preparacion de 1-(2-metil-4-(2,3,4,5-tetrahidro-1- benzazepin-1-il-carbonil)benzilcarbamoil)-l-prolina-n,n-dimetilam ida.

Legal Events

Date Code Title Description
FG Grant or registration